Lauren Carcas, MD

Reshma Mahtani, D.O., is a medical oncologist at Baptist Health Miami Cancer Institute and chief of breast medical oncology at Baptist Health Wellness and Medical Complex. She specializes in the treatment of breast cancer. Prior to joining Baptist Health Cancer Care in 2022, Dr. Mahtani worked as an associate professor of medicine and co-leader of the Breast Cancer Site Disease Group at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine. She also served as the director of community outreach. Dr. Mahtani earned her medical degree at the University of New England College of Osteopathic Medicine in Portland, Maine. She completed an internal medicine internship at Greenwich Hospital, a Yale affiliate, in Greenwich, Conn. She also completed an internal medicine residency and a hematology-oncology fellowship at St. Vincent’s Catholic Medical Center in New York. Dr. Mahtani is an active clinical researcher, helping bring novel breast cancer treatments and clinical trials to patients in South Florida. She has made significant scientific and clinical practice contributions and has received funding from numerous organizations. As a nationally recognized thought leader in breast cancer, she has numerous first-author publications in peer-reviewed journals and has presented her cancer research findings at cancer conferences worldwide. She serves as editor-in-chief for Practice Update, an online medical education platform for physicians, and has served on national committees to recognize cancer clinics that offer quality care across the country. Known for her passion for medical education, she founded an education initiative to ensure that physicians in South Florida know about the latest cancer treatments and can provide evidence-based care. She is also involved in several initiatives that enhance patients’ access to healthcare, as well as community collaborations for education and advocacy. Though she is a passionate researcher, Dr. Mahtani most enjoys spending time with her patients. She believes it is a privilege to be by their side, teaching them about their breast cancer and treatment options. She strives to help every patient find hope through clinical trials and the latest novel treatments for breast cancer.

An internationally recognized expert in radiation therapy for gastrointestinal (GI) cancers, Michael Chuong, M.D., FACRO, is vice chair and medical director of radiation oncology and leads the GI radiation service at Baptist Health. Dr. Chuong earned his medical degree from the University of South Florida College of Medicine and completed his residency training in radiation oncology at the H. Lee Moffitt Cancer Center, where he served as the chief resident. He also serves as the vice chair of education and clinical research and is professor of radiation oncology at the Florida International University Herbert Wertheim College of Medicine. Dr. Chuong is frequently invited to speak around the globe about his clinical expertise and research that is impacting the standard of care, especially related to proton therapy and MRI-guided radiation therapy. Dr. Chuong has co-authored over 100 peer-reviewed manuscripts in prestigious journals such as JAMA Oncology and the International Journal of Radiation Oncology Biology Physics, for which he is the GI section editor. He is a principal investigator for multiple national and international clinical trials that are exploring advanced radiation therapy strategies and unique combinations of radiation therapy with novel therapeutic agents for GI cancers.An active leader in the medical community, Dr. Chuong is the Protocol Monitoring and Review Committee chair at Baptist Health Miami Cancer Institute, Disease Site chair of the Proton Collaborative Group and the Particle Therapy Co-operative Group Gastrointestinal Subcommittee co-chair. He participates as an active member of the NRG Oncology Non-Colorectal GI subcommittee, NRG Oncology Pancreas working group, NRG Oncology International Liaison committee and RTOG Foundation Communications committee.

Rupesh Kotecha, M.D., is a radiation oncologist at Miami Cancer Institute. Dr. Kotecha has specialized training and experience in utilizing the latest in radiation therapy treatment techniques to treat cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiosurgery and stereotactic body radiation therapy. He has a specific interest and expertise in the use of stereotactic radiosurgery in the management of brain metastases to help improve both patient outcomes and quality of life.